These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 7620696

  • 1. The interaction of fluvastatin and cyclosporin A in renal transplant patients.
    Li PK, Mak TW, Wang AY, Lee YT, Leung CB, Lui SF, Lam CW, Lai KN.
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):246-8. PubMed ID: 7620696
    [Abstract] [Full Text] [Related]

  • 2. A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine.
    Goldberg RB, Roth D.
    Am J Cardiol; 1995 Jul 13; 76(2):107A-109A. PubMed ID: 7604782
    [Abstract] [Full Text] [Related]

  • 3. No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
    Fellström B, Abedini S, Holdaas H, Jardine AG, Staffler B, Gimpelewicz C, Assessment of Lescol in Renal Transplantation (ALERT) study group.
    Clin Transplant; 2006 Jul 13; 20(6):732-9. PubMed ID: 17100723
    [Abstract] [Full Text] [Related]

  • 4. Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine.
    Holdaas H, Hartmann A, Stenstrøm J, Dahl KJ, Borge M, Pfister P.
    Am J Cardiol; 1995 Jul 13; 76(2):102A-106A. PubMed ID: 7604781
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B, Kubanek M, Malek I, Vymetalova Y, Hoskova L, Podzimkova M, Kautzner J.
    J Heart Lung Transplant; 2009 Jun 13; 28(6):598-604. PubMed ID: 19481021
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia.
    Insull W, Black D, Dujovne C, Hosking JD, Hunninghake D, Keilson L, Knopp R, McKenney J, Stein E, Troendle AJ.
    Arch Intern Med; 1994 Nov 14; 154(21):2449-55. PubMed ID: 7979841
    [Abstract] [Full Text] [Related]

  • 11. Monitoring of peripheral blood cytotoxic T-cells under fluvastatin treatment in renal transplant recipients.
    Barlage S, Hauser IA, Elbracht R, Abletshauser C, Schmieder RE, Weidinger G, Lackner KJ, Rothe G, Schmitz G.
    J Biol Regul Homeost Agents; 2005 Nov 14; 19(3-4):159-68. PubMed ID: 16602632
    [Abstract] [Full Text] [Related]

  • 12. Fluvastatin as co-medication in heart transplant recipients with elevated creatine-kinase.
    Sadoni S, Kaczmarek I, Delgado O, Schmöckel M, Reichart B, Meiser B.
    Transplant Proc; 2007 Mar 14; 39(2):558-9. PubMed ID: 17362781
    [Abstract] [Full Text] [Related]

  • 13. Fluvastatin in the prevention of renal transplant vasculopathy: results of a prospective, randomized, double-blind, placebo-controlled trial.
    Serón D, Oppenheimer F, Pallardó LM, Lauzurica R, Errasti P, Gomez-Huertas E, Bosmans JL, Sanchez-Plumed J, Romero R, Marques M, Fulladosa X, Moreso F.
    Transplantation; 2008 Jul 15; 86(1):82-7. PubMed ID: 18622282
    [Abstract] [Full Text] [Related]

  • 14. Fluvastatin ameliorates endotoxin induced multiple organ failure in conscious rats.
    Chen CH, Lee RP, Wu WT, Liao KW, Hsu N, Hsu BG.
    Resuscitation; 2007 Jul 15; 74(1):166-74. PubMed ID: 17353078
    [Abstract] [Full Text] [Related]

  • 15. Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: a pooled analysis of thirty clinical trials.
    Winkler K, Ablethauser CB, Gimpelewicz C, Bortolini M, Isaacsohn JL.
    Clin Ther; 2007 Sep 15; 29(9):1987-2000. PubMed ID: 18035198
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation.
    Holdaas H, Fellström B, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Logan JO, Staffler B, Gimpelewicz C, ALERT Study Group.
    Nephrol Dial Transplant; 2005 May 15; 20(5):974-80. PubMed ID: 15784644
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Elderly patients with hypercholesterolaemia: a double-blind study of the efficacy, safety and tolerability of fluvastatin.
    Lye M, Valacio R, Reckless JP, Ghosh AK, Findlay IN, Ghosh MK, Passmore AP, Fulcher RA.
    Coron Artery Dis; 1998 May 15; 9(9):583-90. PubMed ID: 9861520
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.